Cited by

• Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals.

  Panesso D, Reyes J, Rincón S, Díaz L, Galloway-Peña J, Zurita J, Carrillo C, Merentes A, Guzmán M, Adachi JA, Murray BE, Arias CA. Panesso D, et al. J Clin Microbiol. 2010 May;48(5):1562-9. doi: 10.1128/JCM.02526-09. Epub 2010 Mar 10. J Clin Microbiol. 2010. PMID: 20220167 Free PMC article.
• Antibiotic resistance amongst healthcare-associated pathogens in China.

  Yezli S, Li H. Yezli S, et al. Int J Antimicrob Agents. 2012 Nov;40(5):389-97. doi: 10.1016/j.ijantimicag.2012.07.009. Epub 2012 Sep 20. Int J Antimicrob Agents. 2012. PMID: 22999767 Free PMC article. Review.
• Proficiency in detecting vancomycin resistance in enterococci among clinical laboratories in Santiago, Chile.

  Labarca JA, McDonald LC, Pinto ME, Palavecino E, González P, Cona E, Fernández A, Giglio MS, Jarvis WR. Labarca JA, et al. Emerg Infect Dis. 1999 Nov-Dec;5(6):839-40. doi: 10.3201/eid0506.990623. Emerg Infect Dis. 1999. PMID: 10603228 Free PMC article. No abstract available.
• Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil.

  Dalla Costa LM, Reynolds PE, Souza HA, Souza DC, Palepou MF, Woodford N. Dalla Costa LM, et al. Antimicrob Agents Chemother. 2000 Dec;44(12):3444-6. doi: 10.1128/AAC.44.12.3444-3446.2000. Antimicrob Agents Chemother. 2000. PMID: 11083656 Free PMC article.
• First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia.

  Panesso D, Ospina S, Robledo J, Vela MC, Peña J, Hernández O, Reyes J, Arias CA. Panesso D, et al. Emerg Infect Dis. 2002 Sep;8(9):961-5. doi: 10.3201/eid0809.010435. Emerg Infect Dis. 2002. PMID: 12194774 Free PMC article.